发热与中性粒细胞减少：仍是一项挑战。
Fever and neutropenia: still a challenge.
作者信息
DiNubile M J
机构信息
Division of Infectious diseases, Cooper Hospital/University Medical Center, Camden, New Jersey, USA.
出版信息
Contemp Intern Med. 1995 Jan;7(1):35-7, 41-5.
PMID:10150331
Abstract
Neutropenia is a double-edged sword. Fever may be the only manifestation of serious bacterial and fungal infection in neutropenic patients, and untreated occult infection can rapidly progress to septic shock and death.
摘要
中性粒细胞减少是一把双刃剑。发热可能是中性粒细胞减少患者严重细菌和真菌感染的唯一表现，未经治疗的隐匿性感染可迅速发展为感染性休克和死亡。
相似文献
1
Fever and neutropenia: still a challenge.发热与中性粒细胞减少：仍是一项挑战。
Contemp Intern Med. 1995 Jan;7(1):35-7, 41-5.
2
Emergency Department evaluation of patients with fever and chemotherapy-induced neutropenia.急诊科对发热及化疗引起的中性粒细胞减少症患者的评估。
J Emerg Med. 2004 Aug;27(2):115-9. doi: 10.1016/j.jemermed.2004.03.004.
3
Neutropenia and fever.中性粒细胞减少症与发热。
Pediatr Infect Dis. 1983 May-Jun;2(3 Suppl):S14-7.
4
[Fever in patients with cancer].
Rinsho Byori. 2009 May;Suppl 143:112-5.
5
[The treatment of febrile immunosuppressed patient].[发热免疫抑制患者的治疗]
Reumatizam. 2007;54(2):63-6.
6
[Clinical guide for the evaluation and treatment of patients with neutropenia and fever].
Rev Esp Quimioter. 2001 Mar;14(1):75-83.
7
[Fever in the neutropenic patient].
Rev Prat. 2001 Mar 31;51(6):633-7.
8
Development of early neutropenic fever, with or without bacterial infection, is still a significant complication after reduced-intensity stem cell transplantation.早期中性粒细胞减少性发热的出现，无论有无细菌感染，仍是降低强度干细胞移植后的一个重大并发症。
Biol Blood Marrow Transplant. 2004 Jan;10(1):65-72. doi: 10.1016/j.bbmt.2003.09.006.
9
Infectious complications in the critically ill patient with cancer.患有癌症的重症患者的感染性并发症。
Semin Oncol. 2000 Jun;27(3):335-46.
10
Clinical characteristics and therapeutic outcome of patients with febrile neutropenia who present in shock: need for better strategies.出现休克的发热性中性粒细胞减少症患者的临床特征及治疗结果：需要更好的策略
J Infect. 2001 Feb;42(2):120-5. doi: 10.1053/jinf.2001.0798.
引用本文的文献
1
Risk Factors for Infections, Antibiotic Therapy, and Its Impact on Cancer Therapy Outcomes for Patients with Solid Tumors.实体瘤患者感染的危险因素、抗生素治疗及其对癌症治疗结果的影响
Life (Basel). 2021 Dec 11;11(12):1387. doi: 10.3390/life11121387.
2
Impact of time to antibiotic on hospital stay, intensive care unit admission, and mortality in febrile neutropenia.发热性中性粒细胞减少症中抗生素使用时间对住院时间、重症监护病房入住率和死亡率的影响。
Support Care Cancer. 2019 Nov;27(11):4171-4177. doi: 10.1007/s00520-019-04701-8. Epub 2019 Feb 25.
Zotero 插件